Viewing Study NCT06034561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-05-22 @ 1:48 PM
Study NCT ID: NCT06034561
Status: RECRUITING
Last Update Posted: 2025-05-16
First Post: 2023-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Sponsor: Instituto do Cancer do Estado de São Paulo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia, in Relapse View
None Acute Lymphoblastic Leukemia With Failed Remission View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute lymphoblastic leukemia View
None Bortezomib View
None Salvage therapy View
None Bridge therapy View
None Response rate View